Modulating AMPA Receptors for the Treatment of CNS Disorders

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/B978-0-12-409547-2.12654-X
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Elucidation of AMPA receptor–stargazin complexes by cryo–electron microscopy

  2016cited by this paper
• Synthesis and Pharmacology of Mono-, Di-, and Trialkyl-Substituted 7-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides Combined with X-ray Structure Analysis to Understand the Unexpected Structure-Activity Relationship at AMPA Receptors.

  2016cited by this paper
• Architecture of fully occupied GluA2 AMPA receptor–TARP complex elucidated by cryo-EM

  2016cited by this paper
• Discovery and Characterization of AMPA Receptor Modulators Selective for TARP-γ8

  2016cited by this paper
• Discovery of the First α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist Dependent upon Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8.

  2016cited by this paper
• Structure and organization of heteromeric AMPA-type glutamate receptors

  2016cited by this paper
• The Safety and Efficacy of PF-04958242 in Age-Related Sensorineural Hearing Loss: A Randomized Clinical Trial.

  2015cited by this paper
• The discovery and characterization of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiator N-{(3S,4S)-4-[4-(5-cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242).

  2015cited by this paper
• Perampanel in the treatment of partial seizures: Time to onset and duration of most common adverse events from pooled Phase III and extension studies.

  2015cited by this paper
• AMPA receptor-positive allosteric modulators for the treatment of schizophrenia: an overview of recent patent applications.

  2015cited by this paper
• AMPA receptor potentiators: from drug design to cognitive enhancement.

  2015cited by this paper
• Rational Design of a Novel AMPA Receptor Modulator through a Hybridization Approach.

  2015cited by this paper
• Thermodynamic Characterization of New Positive Allosteric Modulators Binding to the Glutamate Receptor A2 Ligand-Binding Domain: Combining Experimental and Computational Methods Unravels Differences in Driving Forces

  2014cited by this paper
• Structure and dynamics of AMPA receptor GluA2 in resting, pre-open, and desensitized states.

  2014cited by this paper
• 1-(1,3-Benzodioxol-5-yl-carbo-nyl) piperidine, a modulator of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor, ameliorates exercise-induced fatigue in mice.

  2014cited by this paper
• Design, stereoselective synthesis, configurational stability and biological activity of 7-chloro-9-(furan-3-yl)-2,3,3a,4-tetrahydro-1H-benzo[e]pyrrolo[2,1-c][1,2,4]thiadiazine 5,5-dioxide.

  2014cited by this paper
• Structure of an agonist-bound ionotropic glutamate receptor

  2014cited by this paper
• Positive allosteric modulators of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors belonging to 4-cyclopropyl-3,4-dihydro-2h-1,2,4-pyridothiadiazine dioxides and diversely chloro-substituted 4-cyclopropyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides.

  2014cited by this paper
• Structural mechanism of glutamate receptor activation and desensitization

  2014cited by this paper
• Mapping the Interaction Sites between AMPA Receptors and TARPs Reveals a Role for the Receptor N-Terminal Domain in Channel Gating

  2014cited by this paper
• Assembly of AMPA receptors: mechanisms and regulation

  2014cited by this paper
• AMPA receptor positive allosteric modulators: a patent review

  2013cited by this paper
• Synthesis, pharmacological and structural characterization, and thermodynamic aspects of GluA2-positive allosteric modulators with a 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide scaffold.

  2013cited by this paper
• Discovery and characterization of a novel dihydroisoxazole class of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiators.

  2013cited by this paper
• Allosteric modulators for the treatment of schizophrenia: targeting glutamatergic networks.

  2013cited by this paper
• Positive Allosteric Modulation of AMPA Receptors from Efficacy to Toxicity: The Interspecies Exposure-Response Continuum of the Novel Potentiator PF-4778574

  2013cited by this paper
• AMPAKINE enhancement of social interaction in the BTBR mouse model of autism.

  2013cited by this paper
• Development of thiophenic analogues of benzothiadiazine dioxides as new powerful potentiators of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) receptors.

  2013cited by this paper
• New AMPA antagonists in epilepsy

  2012cited by this paper
• Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease

  2012cited by this paper
• Using Simcyp to project human oral pharmacokinetic variability in early drug research to mitigate mechanism‐based adverse events

  2012cited by this paper
• The regulation of glutamate receptor trafficking and function by TARPs and other transmembrane auxiliary subunits.

  2012cited by this paper
• Discovery of 2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl)benzonitrile (perampanel): a novel, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) receptor antagonist.

  2012cited by this paper
• Benzotriazinone and Benzopyrimidinone Derivatives as Potent Positive Allosteric AMPA Receptor Modulators.

  2012cited by this paper
• Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial

  2012cited by this paper
• NMDA receptor and schizophrenia: a brief history.

  2012cited by this paper
• Neuron NeuroResource High-Resolution Proteomics Unravel Architecture and Molecular Diversity of Native AMPA Receptor Complexes

  2012cited by this paper
• AMPA receptors as drug targets in neurological disease – advantages, caveats, and future outlook

  2012cited by this paper
• A translational approach to evaluate the efficacy and safety of the novel AMPA receptor positive allosteric modulator org 26576 in adult attention-deficit/hyperactivity disorder.

  2012cited by this paper
• Benzoxazinones as potent positive allosteric AMPA receptor modulators: part I.

  2011cited by this paper
• Revisiting AMPA Receptors as an Antiepileptic Drug Target

  2011cited by this paper
• Integration of lead optimization with crystallography for a membrane-bound ion channel target: discovery of a new class of AMPA receptor positive allosteric modulators.

  2011cited by this paper
• An Emerging Role for TARPs in Neuropsychiatric Disorders

  2011cited by this paper
• New substituted aryl esters and aryl amides of 3,4-dihydro-2H-1,2,4- benzothiadiazine 1,1-dioxides as positive allosteric modulators of AMPA receptors

  2011cited by this paper
• The expanding social network of ionotropic glutamate receptors: TARPs and other transmembrane auxiliary subunits.

  2011cited by this paper
• Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States.

  2011cited by this paper
• Substituted benzoxazinones as potent positive allosteric AMPA receptor modulators: part II.

  2011cited by this paper
• Transmembrane AMPA Receptor Regulatory Proteins and Cornichon-2 Allosterically Regulate AMPA Receptor Antagonists and Potentiators*

  2011cited by this paper
• Benzobistriazinones and related heterocyclic ring systems as potent, orally bioavailable positive allosteric AMPA receptor modulators.

  2011cited by this paper
• Structure based evolution of a novel series of positive modulators of the AMPA receptor.

  2011cited by this paper
• Species Independence in Brain Tissue Binding Using Brain Homogenates

  2011cited by this paper
• A novel series of positive modulators of the AMPA receptor: structure-based lead optimization.

  2010cited by this paper
• Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction.

  2010cited by this paper
• N-substituted pyrrolidines and tetrahydrofurans as novel AMPAR positive modulators.

  2010cited by this paper
• High-throughput Screening in Embryonic Stem Cell-derived Neurons Identifies Potentiators of α-Amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type Glutamate Receptors

  2010cited by this paper
• Glutamate Receptor Ion Channels: Structure, Regulation, and Function

  2010cited by this paper
• Recent advances in the discovery of selective AMPA receptor positive allosteric modulators.

  2010cited by this paper
• New fluorinated 1,2,4-benzothiadiazine 1,1-dioxides: discovery of an orally active cognitive enhancer acting through potentiation of the 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors.

  2010cited by this paper
• Positive allosteric modulators of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor.

  2010cited by this paper
• A novel series of positive modulators of the AMPA receptor: discovery and structure based hit-to-lead studies.

  2010cited by this paper
• TARPs differentially decorate AMPA receptors to specify neuropharmacology.

  2010cited by this paper
• Challenges for and current status of research into positive modulators of AMPA receptors

  2010cited by this paper
• alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.

  2010cited by this paper
• Regulation of ionotropic glutamate receptors by their auxiliary subunits.

  2010cited by this paper
• Discovery of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1H-inden-2-yl]-2-propanesulfonamide, a novel clinical AMPA receptor positive modulator.

  2010cited by this paper
• Crystal structure and association behaviour of the GluR2 amino‐terminal domain

  2009cited by this paper
• Probing the allosteric modulator binding site of GluR2 with thiazide derivatives.

  2009cited by this paper
• Targeting AMPA and kainate receptors in neurological disease: therapies on the horizon?

  2009cited by this paper
• Functional Proteomics Identify Cornichon Proteins as Auxiliary Subunits of AMPA Receptors

  2009cited by this paper
• Flip and flop: a molecular determinant for AMPA receptor channel opening.

  2009cited by this paper
• X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor

  2009cited by this paper
• More AMPAR Garnish

  2009cited by this paper
• The role of AMPA receptor modulation in the treatment of neuropsychiatric diseases.

  2008cited by this paper
• Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717

  2008cited by this paper
• Hormesis and medicine.

  2008cited by this paper
• Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

  2008cited by this paper
• Regulation of AMPA receptor gating and pharmacology by TARP auxiliary subunits.

  2008cited by this paper
• Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat

  2008cited by this paper
• Structural aspects of AMPA receptor activation, desensitization and deactivation.

  2007cited by this paper
• Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.

  2007cited by this paper
• AMPA receptors and stargazin-like transmembrane AMPA receptor-regulatory proteins mediate hippocampal kainate neurotoxicity

  2007cited by this paper
• Ampakine (CX717) effects on performance and alertness during simulated night shift work.

  2007cited by this paper
• AMPA potentiator treatment of cognitive deficits in Alzheimer disease

  2007cited by this paper
• Pharmacological Characterization of cGMP Regulation by the Biarylpropylsulfonamide Class of Positive, Allosteric Modulators of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors

  2006cited by this paper
• Ampakines and the threefold path to cognitive enhancement.

  2006cited by this paper
• A novel class of AMPA receptor allosteric modulators. Part 1: design, synthesis, and SAR of 3-aryl-4-cyano-5-substituted-heteroaryl-2-carboxylic acid derivatives.

  2006cited by this paper
• Effect of CX516, an AMPA-Modulating Compound, on Cognition and Behavior in Fragile X Syndrome: AControlled Trial

  2006cited by this paper
• Glutamate receptors at atomic resolution

  2006cited by this paper
• Cyclothiazide induces robust epileptiform activity in rat hippocampal neurons both in vitro and in vivo

  2006cited by this paper
• A novel class of positive allosteric modulators of AMPA receptors: design, synthesis, and structure-activity relationships of 3-biphenyl-4-yl-4-cyano-5-ethyl-1-methyl-1H-pyrrole-2-carboxylic acid, LY2059346.

  2006cited by this paper
• LY404187: a novel positive allosteric modulator of AMPA receptors.

  2006cited by this paper
• Dopamine Receptor Stimulation Modulates AMPA Receptor Synaptic Insertion in Prefrontal Cortex Neurons

  2005cited by this paper
• A comprehensive listing of bioactivation pathways of organic functional groups.

  2005cited by this paper
• Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors

  2005cited by this paper
• Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data

  2005cited by this paper
• Ionotropic and metabotropic glutamate receptor structure and pharmacology

  2005cited by this paper
• The 5-HT6 Receptor Antagonist SB-271046 Reverses Scopolamine-Disrupted Consolidation of a Passive Avoidance Task and Ameliorates Spatial Task Deficits in Aged Rats

  2004cited by this paper
• Expression of transcripts encoding AMPA receptor subunits and associated postsynaptic proteins in the macaque brain

  2004cited by this paper
• Structure and function of glutamate receptor ion channels.

  2004cited by this paper
• Structure and function of AMPA receptors

  2004cited by this paper

• Small-molecule targeting AMPA-mediated excitotoxicity has therapeutic effects in mouse models for multiple sclerosis

  2023cites this paper
• Inhibition of AMPA receptors containing TARP γ-8 with JNJ-55511118 shows preclinical efficacy for pharmacotherapeutic treatment of chronic repetitive alcohol self-administration.

  2021cites this paper
• Allosteric Modulation of Ionotropic Glutamate Receptors: An Outlook on New Therapeutic Approaches To Treat Central Nervous System Disorders.

  2019cites this paper
• Allosteric Modulators of Potential Targets Related to Alzheimer's Disease: a Review

  2019cites this paper